HomePharmaceutical

Pharmaceutical

DHL invests US$15m in Singapore pharma hub to bolster supply chains

DHL has committed US$15 million to launch its first pharmaceutical logistics facility in Southeast...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

BD tackles shortage in healthcare professionals with robot pharmacy technology

Singapore hospitals are deploying robotic pharmacy technology to ease healthcare workforce shortages, cut patient...

Latest articles

Did The EV Component Pivot Save Duty Free International’s Q1 FY2027

Can an EV Pivot Offset the Collapse of a Border-Retail Empire? The first-quarter results for...

Foundation Healthcare’s IPO Breakdown

The Consolidation Play in a Fragmented Market The initial public offering of Foundation Healthcare Holdings...

XMH Holdings FY2026 Profits Surge While Debt Is Wiped Out

4 Takeaways from the FY2026 Results XMH Holdings Ltd has executed a radical balance sheet...

Fortress Minerals 1Q FY2027 Profit Surges As Efficiency Wins

Fortress Minerals is Bucking the Global Steel Slump The global steel industry is grappling with...

Keep exploring

Did The EV Component Pivot Save Duty Free International’s Q1 FY2027

Can an EV Pivot Offset the Collapse of a Border-Retail Empire? The first-quarter results for Duty Free International Limited for the period ended 31 May 2026 present a jarring paradox. A headline-grabbing 89.9% revenue surge suggests a business in peak health, yet this figure masks...

Foundation Healthcare’s IPO Breakdown

The Consolidation Play in a Fragmented Market The initial public offering of Foundation Healthcare Holdings Limited at S$0.76 per share is a landmark event for the SGX Mainboard, but investors should view it as an infrastructure play rather than a traditional medical listing. The offering...

Keep exploring